{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T03:47:56Z","timestamp":1767066476845,"version":"3.40.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jinan Microecological Biomedicine Shandong Laboratory","award":["JNL-2022001A","JNL-2022001A","JNL-2022001A","JNL-2022001A"],"award-info":[{"award-number":["JNL-2022001A","JNL-2022001A","JNL-2022001A","JNL-2022001A"]}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2021YFC2301804\uff0c2022YFC3602000","2021YFC2301804\uff0c2022YFC3602000","2021YFC2301804\uff0c2022YFC3602000","2021YFC2301804\uff0c2022YFC3602000"],"award-info":[{"award-number":["2021YFC2301804\uff0c2022YFC3602000","2021YFC2301804\uff0c2022YFC3602000","2021YFC2301804\uff0c2022YFC3602000","2021YFC2301804\uff0c2022YFC3602000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32270068","32270068","32270068","32270068"],"award-info":[{"award-number":["32270068","32270068","32270068","32270068"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shandong Provincial Laboratory Project","award":["SYS202202","SYS202202","SYS202202","SYS202202"],"award-info":[{"award-number":["SYS202202","SYS202202","SYS202202","SYS202202"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11040-z","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T15:11:32Z","timestamp":1745939492000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical manifestations of SARS-CoV-2 Omicron infection is associated with the stage of liver cirrhosis"],"prefix":"10.1186","volume":"25","author":[{"given":"Fengjiao","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingxiao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanfei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanjuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"11040_CR1","doi-asserted-by":"crossref","unstructured":"Giuliani F, Oros D, Gunier RB, Deantoni S, Rauch S, Casale R et al. Effects of prenatal exposure to maternal COVID-19 and perinatal care on neonatal outcome: results from the INTERCOVID Multinational Cohort Study. Am J Obstet Gynecol. 2022;227:488.e1-488.e17.","DOI":"10.1016\/j.ajog.2022.04.019"},{"key":"11040_CR2","doi-asserted-by":"publisher","first-page":"zrac052","DOI":"10.1093\/bjsopen\/zrac052","volume":"6","author":"CHOLECOVID Collaborative","year":"2022","unstructured":"CHOLECOVID Collaborative. Global overview of the management of acute cholecystitis during the COVID-19 pandemic (CHOLECOVID study). BJS Open. 2022;6:zrac052.","journal-title":"BJS Open"},{"key":"11040_CR3","first-page":"4059","volume":"24","author":"L Valdenassi","year":"2020","unstructured":"Valdenassi L, Franzini M, Ricevuti G, Rinaldi L, Galoforo AC, Tirelli U. Potential mechanisms by which the oxygen-ozone (O2-O3) therapy could contribute to the treatment against the coronavirus COVID-19. Eur Rev Med Pharmacol Sci. 2020;24:4059\u201361.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"11040_CR4","doi-asserted-by":"publisher","first-page":"e403","DOI":"10.1093\/cid\/ciac014","volume":"75","author":"A Marrone","year":"2022","unstructured":"Marrone A, Nevola R, Sellitto A, Cozzolino D, Romano C, Cuomo G, et al. Remdesivir plus dexamethasone versus dexamethasone alone for the treatment of coronavirus disease 2019 (COVID-19) patients requiring supplemental O2 therapy: A prospective controlled nonrandomized study. Clin Infect Dis. 2022;75:e403\u20139.","journal-title":"Clin Infect Dis"},{"key":"11040_CR5","doi-asserted-by":"publisher","first-page":"e28138","DOI":"10.1002\/jmv.28138","volume":"95","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Zhi H, Teng Y. The outbreak of SARS-CoV-2 Omicron lineages, immune escape, and vaccine effectivity. J Med Virol. 2023;95:e28138.","journal-title":"J Med Virol"},{"key":"11040_CR6","doi-asserted-by":"publisher","first-page":"2191738","DOI":"10.1080\/22221751.2023.2191738","volume":"12","author":"L Zheng","year":"2023","unstructured":"Zheng L, Liu S, Lu F. Impact of National Omicron outbreak at the end of 2022 on the future outlook of COVID-19 in China. Emerg Microbes Infections. 2023;12:2191738.","journal-title":"Emerg Microbes Infections"},{"key":"11040_CR7","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41577-022-00681-9","volume":"22","author":"L Pia","year":"2022","unstructured":"Pia L, Rowland-Jones S. Omicron entry route. Nat Rev Immunol. 2022;22:144.","journal-title":"Nat Rev Immunol"},{"key":"11040_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cytogfr.2021.06.001","volume":"63","author":"B Cosar","year":"2022","unstructured":"Cosar B, Karagulleoglu ZY, Unal S, Ince AT, Uncuoglu DB, Tuncer G, et al. SARS-CoV-2 mutations and their viral variants. Cytokine Growth Factor Rev. 2022;63:10\u201322.","journal-title":"Cytokine Growth Factor Rev"},{"key":"11040_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12998\/wjcc.v10.i1.1","volume":"10","author":"S-Y Ren","year":"2022","unstructured":"Ren S-Y, Wang W-B, Gao R-D, Zhou A-M. Omicron variant (B.1.1.529) of SARS-CoV-2: mutation, infectivity, transmission, and vaccine resistance. World J Clin Cases. 2022;10:1\u201311.","journal-title":"World J Clin Cases"},{"key":"11040_CR10","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1111\/1751-7915.14064","volume":"15","author":"H Br\u00fcssow","year":"2022","unstructured":"Br\u00fcssow H. COVID-19: Omicron - the latest, the least virulent, but probably not the last variant of concern of SARS-CoV-2. Microb Biotechnol. 2022;15:1927\u201339.","journal-title":"Microb Biotechnol"},{"key":"11040_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jiph.2022.11.024","volume":"16","author":"K Dhama","year":"2023","unstructured":"Dhama K, Nainu F, Frediansyah A, Yatoo MI, Mohapatra RK, Chakraborty S, et al. Global emerging Omicron variant of SARS-CoV-2: impacts, challenges and strategies. J Infect Public Health. 2023;16:4\u201314.","journal-title":"J Infect Public Health"},{"key":"11040_CR12","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","volume":"323","author":"S Richardson","year":"2020","unstructured":"Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the new York City area. JAMA. 2020;323:2052.","journal-title":"JAMA"},{"key":"11040_CR13","doi-asserted-by":"publisher","first-page":"e0243700","DOI":"10.1371\/journal.pone.0243700","volume":"15","author":"R Galiero","year":"2020","unstructured":"Galiero R, Pafundi PC, Simeon V, Rinaldi L, Perrella A, Vetrano E, et al. Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: findings from COVOCA study. PLoS ONE. 2020;15:e0243700.","journal-title":"PLoS ONE"},{"key":"11040_CR14","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1126\/science.acx9782","volume":"374","author":"K Kupferschmidt","year":"2021","unstructured":"Kupferschmidt K, Vogel G. How bad is Omicron? Some clues are emerging. Science. 2021;374:1304\u20135.","journal-title":"Science"},{"key":"11040_CR15","doi-asserted-by":"publisher","first-page":"taac037","DOI":"10.1093\/jtm\/taac037","volume":"29","author":"Y Liu","year":"2022","unstructured":"Liu Y, Rockl\u00f6v J. The effective reproductive number of the Omicron variant of SARS-CoV-2 is several times relative to Delta. J Travel Med. 2022;29:taac037.","journal-title":"J Travel Med"},{"key":"11040_CR16","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jhep.2019.03.004","volume":"71","author":"J Xiao","year":"2019","unstructured":"Xiao J, Wang F, Wong N-K, He J, Zhang R, Sun R, et al. Global liver disease burdens and research trends: analysis from a Chinese perspective. J Hepatol. 2019;71:212\u201321.","journal-title":"J Hepatol"},{"key":"11040_CR17","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1007\/s12072-020-10078-2","volume":"14","author":"AJ Kovalic","year":"2020","unstructured":"Kovalic AJ, Satapathy SK, Thuluvath PJ. Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis. Hepatol Int. 2020;14:612\u201320.","journal-title":"Hepatol Int"},{"key":"11040_CR18","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jhep.2020.09.024","volume":"74","author":"T Marjot","year":"2021","unstructured":"Marjot T, Moon AM, Cook JA, Abd-Elsalam S, Aloman C, Armstrong MJ, et al. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study. J Hepatol. 2021;74:567\u201377.","journal-title":"J Hepatol"},{"key":"11040_CR19","doi-asserted-by":"crossref","unstructured":"H L, R T. SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease. Gut. 2023;72.","DOI":"10.1136\/gutjnl-2023-329623"},{"key":"11040_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/IM9.0000000000000092","volume":"4","author":"Z Chen","year":"2022","unstructured":"Chen Z. Valuing the prevention and treatment of liver disease to promote human wellbeing. Infect Microbes Dis. 2022;4:47\u20138.","journal-title":"Infect Microbes Dis"},{"key":"11040_CR21","doi-asserted-by":"crossref","unstructured":"Kulkarni AV, Metage CS, Gora BA, Tirumalle S, Rakam K, Satyavadi A et al. SARS-CoV-2 Omicron variant infection was associated with higher morbidity in patients with cirrhosis. Gut. 2022;:gutjnl\u20132022.","DOI":"10.1136\/gutjnl-2022-328451"},{"key":"11040_CR22","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1080\/21505594.2021.1909894","volume":"12","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Wu D, Shi X, Liu S, Hu X, Zhou C, et al. High Child-Pugh and CRUB65 scores predict mortality of decompensated cirrhosis patients with COVID-19: A 23-center, retrospective study. Virulence. 2021;12:1199\u2013208.","journal-title":"Virulence"},{"key":"11040_CR23","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s43055-020-00309-9","volume":"51","author":"W Gouda","year":"2020","unstructured":"Gouda W, Yasin R. COVID-19 disease: CT pneumonia analysis prototype by using artificial intelligence, predicting the disease severity. Egypt J Radiol Nucl Med. 2020;51:196.","journal-title":"Egypt J Radiol Nucl Med"},{"key":"11040_CR24","doi-asserted-by":"publisher","first-page":"5783","DOI":"10.21037\/qims-23-31","volume":"13","author":"H Zhang","year":"2023","unstructured":"Zhang H, Wang D, Li W, Tian Z, Ma L, Guo J, et al. Artificial intelligence system-based histogram analysis of computed tomography features to predict tumor invasiveness of ground-glass nodules. Quant Imaging Med Surg. 2023;13:5783\u201395.","journal-title":"Quant Imaging Med Surg"},{"key":"11040_CR25","doi-asserted-by":"publisher","first-page":"e16577","DOI":"10.7717\/peerj.16577","volume":"12","author":"W Fan","year":"2024","unstructured":"Fan W, Liu H, Zhang Y, Chen X, Huang M, Xu B. Diagnostic value of artificial intelligence based on computed tomography (CT) density in benign and malignant pulmonary nodules: a retrospective investigation. PeerJ. 2024;12:e16577.","journal-title":"PeerJ"},{"key":"11040_CR26","doi-asserted-by":"publisher","first-page":"e0294899","DOI":"10.1371\/journal.pone.0294899","volume":"18","author":"A Arian","year":"2023","unstructured":"Arian A, Mehrabi Nejad M-M, Zoorpaikar M, Hasanzadeh N, Sotoudeh-Paima S, Kolahi S, et al. Accuracy of artificial intelligence CT quantification in predicting COVID-19 subjects\u2019 prognosis. PLoS ONE. 2023;18:e0294899.","journal-title":"PLoS ONE"},{"key":"11040_CR27","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1136\/gutjnl-2020-322118","volume":"70","author":"JS Bajaj","year":"2021","unstructured":"Bajaj JS, Garcia-Tsao G, Biggins SW, Kamath PS, Wong F, McGeorge S, et al. Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort. Gut. 2021;70:531\u20136.","journal-title":"Gut"},{"key":"11040_CR28","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1007\/s12072-020-10072-8","volume":"14","author":"SK Sarin","year":"2020","unstructured":"Sarin SK, Choudhury A, Lau GK, Zheng M-H, Ji D, Abd-Elsalam S, et al. Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; the APCOLIS study (APASL COVID-19 liver injury spectrum study). Hepatol Int. 2020;14:690\u2013700.","journal-title":"Hepatol Int"},{"key":"11040_CR29","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jhep.2020.05.013","volume":"73","author":"AM Moon","year":"2020","unstructured":"Moon AM, Webb GJ, Aloman C, Armstrong MJ, Cargill T, Dhanasekaran R, et al. High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: preliminary results from an international registry. J Hepatol. 2020;73:705\u20138.","journal-title":"J Hepatol"},{"key":"11040_CR30","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41575-021-00520-7","volume":"19","author":"A Albillos","year":"2022","unstructured":"Albillos A, Martin-Mateos R, Van der Merwe S, Wiest R, Jalan R, \u00c1lvarez-Mon M. Cirrhosis-associated immune dysfunction. Nat Rev Gastroenterol Hepatol. 2022;19:112\u201334.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"11040_CR31","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.eimc.2022.02.006","volume":"41","author":"DK Nomah","year":"2023","unstructured":"Nomah DK, D\u00edaz Y, Vivanco-Hidalgo RM, Casabona J, Miro JM, Reyes-Urue\u00f1a J, et al. Population-based assessment of SARS-CoV-2 infection among people living with HIV and the general population of Catalonia (March-December, 2020). Enferm Infecc Microbiol Clin (Engl Ed). 2023;41:294\u20137.","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"key":"11040_CR32","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/QAD.0000000000003129","volume":"36","author":"MS Durstenfeld","year":"2022","unstructured":"Durstenfeld MS, Sun K, Ma Y, Rodriguez F, Secemsky EA, Parikh RV, et al. Association of HIV infection with outcomes among adults hospitalized with COVID-19. AIDS. 2022;36:391\u20138.","journal-title":"AIDS"},{"key":"11040_CR33","doi-asserted-by":"publisher","first-page":"05036","DOI":"10.7189\/jogh.12.05036","volume":"12","author":"G Favara","year":"2022","unstructured":"Favara G, Barchitta M, Maugeri A, Faro G, Agodi A. HIV infection does not affect the risk of death of COVID-19 patients: A systematic review and meta-analysis of epidemiological studies. J Glob Health. 2022;12:05036.","journal-title":"J Glob Health"},{"key":"11040_CR34","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jiph.2022.05.006","volume":"15","author":"T Dzinamarira","year":"2022","unstructured":"Dzinamarira T, Murewanhema G, Chitungo I, Ngara B, Nkambule SJ, Madziva R, et al. Risk of mortality in HIV-infected COVID-19 patients: A systematic review and meta-analysis. J Infect Public Health. 2022;15:654\u201361.","journal-title":"J Infect Public Health"},{"key":"11040_CR35","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1186\/s12879-023-08768-x","volume":"23","author":"Y Tan","year":"2023","unstructured":"Tan Y, Wu S, Guo W, Liu J, Ming F, Zou S, et al. Are people living with HIV have a low vulnerability to Omicron variant infection: results from a cross-sectional study in China. BMC Infect Dis. 2023;23:795.","journal-title":"BMC Infect Dis"},{"key":"11040_CR36","doi-asserted-by":"publisher","first-page":"775","DOI":"10.26719\/emhj.23.107","volume":"29","author":"HA Noureldine","year":"2023","unstructured":"Noureldine HA, Chedid G, Abdessamad H, Costanian C, Maamari J, Al Nakib M, et al. COVID-19 among people living with HIV in Lebanon. East Mediterr Health J. 2023;29:775\u201382.","journal-title":"East Mediterr Health J"},{"key":"11040_CR37","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","volume":"61","author":"A Albillos","year":"2014","unstructured":"Albillos A, Lario M, \u00c1lvarez-Mon M. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. J Hepatol. 2014;61:1385\u201396.","journal-title":"J Hepatol"},{"key":"11040_CR38","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/path.5642","volume":"254","author":"LE van Eijk","year":"2021","unstructured":"van Eijk LE, Binkhorst M, Bourgonje AR, Offringa AK, Mulder DJ, Bos EM, et al. COVID-19: immunopathology, pathophysiological mechanisms, and treatment options. J Pathol. 2021;254:307\u201331.","journal-title":"J Pathol"},{"key":"11040_CR39","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jhep.2020.06.001","volume":"73","author":"M Iavarone","year":"2020","unstructured":"Iavarone M, D\u2019Ambrosio R, Soria A, Triolo M, Pugliese N, Del Poggio P, et al. High rates of 30-day mortality in patients with cirrhosis and COVID-19. J Hepatol. 2020;73:1063\u201371.","journal-title":"J Hepatol"},{"key":"11040_CR40","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.4254\/wjh.v12.i12.1182","volume":"12","author":"P Anirvan","year":"2020","unstructured":"Anirvan P, Bharali P, Gogoi M, Thuluvath PJ, Singh SP, Satapathy SK. Liver injury in COVID-19: the hepatic aspect of the respiratory syndrome - what we know so Far. World J Hepatol. 2020;12:1182\u201397.","journal-title":"World J Hepatol"},{"key":"11040_CR41","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1097\/MEG.0000000000002034","volume":"33","author":"P Anirvan","year":"2021","unstructured":"Anirvan P, Narain S, Hajizadeh N, Aloor FZ, Singh SP, Satapathy SK. Cytokine-induced liver injury in coronavirus disease-2019 (COVID-19): untangling the knots. Eur J Gastroen Hepat. 2021;33:e42\u20139.","journal-title":"Eur J Gastroen Hepat"},{"key":"11040_CR42","doi-asserted-by":"publisher","first-page":"1049006","DOI":"10.3389\/fpubh.2022.1049006","volume":"10","author":"J Zhang","year":"2022","unstructured":"Zhang J, Zhao D, Hu J, Huang X, Gu Q, Tao Z. Hepatic dysfunctions in COVID-19 patients infected by the Omicron variant of SARS-CoV-2. Front Public Health. 2022;10:1049006.","journal-title":"Front Public Health"},{"key":"11040_CR43","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.1007\/s10620-023-08105-x","volume":"68","author":"PA Twohig","year":"2023","unstructured":"Twohig PA, Scholten K, Schissel M, Brittan K, Barbaretta J, Samson K, et al. Mortality increased among hospitalized patients with cirrhosis before and following different waves of the COVID-19 pandemic. Dig Dis Sci. 2023;68:4381\u20138.","journal-title":"Dig Dis Sci"},{"key":"11040_CR44","first-page":"9454","volume":"27","author":"MM Rando","year":"2023","unstructured":"Rando MM, Biscetti F, Masciocchi C, Capocchiano ND, Nicolazzi MA, Nardella E, et al. Identification of early predictors of clinical outcomes of COVID-19 outbreak in an Italian single center using a machine-learning approach. Eur Rev Med Pharmacol Sci. 2023;27:9454\u201369.","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11040-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11040-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11040-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T17:02:51Z","timestamp":1745946171000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11040-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11040"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11040-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"4 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study received approval from the Institutional Review Boards at the The First Affiliated Hospital, Zhejiang University School of Medicine (IIT20210312B-R1). As a retrospective study using anonymized clinical data, the ethics committee waived the requirement for individual patient consent. We certify that the study was performed in accordance with the 1964 Declaration of Helsinki and later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"630"}}